New drugs, tests, and policies suggest steady and continued future growth in the space, though public awareness of personalized medicine continues to lag.
A workshop concludes that for some studies there is no good alternative to using human fetal tissue, ScienceInsider reports.
A partial US government shutdown would affect scientific research, Nature News says.
The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.
The company will donate the Infinium Global Diversity array it developed for the program to the three All of Us genome centers to process up to 1 million samples.
The US Department of Health and Human Services says it has not cancelled a fetal tissue contract with a University of California, San Francisco, lab, Science reports.
The US National Institutes of Health is sending tissue chips to space to study physiological changes that astronauts undergo in microgravity.
The endorsement is the agency's first through the Human Variant Database Program, for which it released final guidance earlier this year.
NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.
According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.
A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.
In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.